University of North Carolina at Chapel Hill/ University of North Carolina Medical Center is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Chronic Lymphocytic Leukemia.
Sponsors: Vironexis Biotherapeutics Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Chronic Lymphocytic Leukemia.
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.